Home/Peptides/Peptides for Healing

Peptides for Healing: Your Complete Guide to BPC-157, TB-500, and GHK-Cu

Therapeutic peptides represent a new frontier in regenerative medicine. This in-depth guide covers the three most studied healing peptides: how they work, what conditions they address, and what the clinical evidence says: to help you make informed decisions with your physician.

Published January 10, 2026
Updated March 15, 2026
15 min read read

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about your health. Individual results may vary.

What Are Therapeutic Peptides?

If you've heard the word "peptides" thrown around in health circles and aren't sure what to make of it, you're not alone. At their core, peptides are short chains of amino acids, typically 2 to 50 amino acids long, that act as signaling molecules. They're the body's internal messengers, telling cells to repair tissue, calm inflammation, release hormones, or mount an immune response.

Here's the thing: your body already makes thousands of peptides. Insulin is a peptide. Oxytocin is a peptide. Growth hormone-releasing hormone is a peptide. Therapeutic peptide therapy works with this existing signaling system. It provides specific peptides in concentrated form to amplify particular biological processes, especially tissue repair and regeneration.

Three peptides have stood out in regenerative medicine: BPC-157 (Body Protection Compound-157), TB-500 (a synthetic fragment of Thymosin Beta-4), and GHK-Cu (glycyl-L-histidyl-L-lysine copper complex). They each work through different mechanisms, but they often complement each other, which is why physicians frequently combine them in treatment protocols.

There's no single peptide that does everything. Different peptides address different biological processes, and the protocols that get the best results are the ones tailored to a specific patient's condition, health status, and goals. That's why physician supervision isn't optional. It's what makes the difference between a thoughtful protocol and guesswork.

BPC-157: The Body Protection Compound

BPC-157 is a 15-amino acid peptide originally isolated from human gastric juice, which is a strange origin story for something with such broad healing effects. Despite coming from the stomach, BPC-157 has shown broad regenerative properties across nearly every tissue type researchers have tested: tendons, ligaments, muscle, bone, intestinal lining, and nervous tissue.[1]

Key Properties

  • Angiogenesis: Promotes formation of new blood vessels, increasing nutrient and oxygen delivery to damaged tissue
  • Growth factor modulation: Upregulates VEGF, EGF, and growth hormone receptors, creating a pro-healing environment
  • Anti-inflammatory: Modulates the nitric oxide system and reduces pro-inflammatory cytokines
  • Neuroprotective: Research demonstrates protective effects on neural tissue, including potential benefits for gut-brain axis function
  • Gut healing: Originally studied for gastrointestinal conditions, BPC-157 has strong evidence for healing intestinal damage, including NSAID-induced damage
  • Tendon and ligament repair: One of the most studied applications, with multiple animal studies demonstrating accelerated healing

How BPC-157 Is Used

BPC-157 is most commonly administered via subcutaneous injection, either systemically (abdominal area) or locally near the injury site. Oral formulations exist and may be preferred for gastrointestinal applications. Treatment protocols typically run 6–12 weeks, with dosing determined by the physician based on the condition being treated.[2]

For detailed information on BPC-157 for specific conditions, see our guides on peptides for tendon repair and peptides for arthritis.

TB-500 (Thymosin Beta-4)

TB-500 is a synthetic version of Thymosin Beta-4 (Tβ4), a 43-amino acid peptide found in virtually every cell in your body. Scientists originally flagged it for its role in immune function, but it turned out to be far more versatile than expected. It's now recognized as a critical player in tissue repair, cell migration, and inflammation resolution.[3]

Key Properties

  • Cell migration: TB-500 upregulates actin, the protein that forms cell structural frameworks, enabling faster migration of repair cells to injury sites
  • Anti-inflammatory: Potent reducer of pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6), addressing the chronic low-grade inflammation that impedes healing
  • Stem cell activation: TB-500 activates resident stem cells in damaged tissue, promoting differentiation into functional cells
  • Extracellular matrix remodeling: Supports production and organization of the extracellular matrix critical for tissue structural integrity
  • Blood vessel formation: Promotes angiogenesis through mechanisms complementary to BPC-157
  • Cardiac protection: Research demonstrates cardioprotective effects, including support for cardiomyocyte survival after cardiac events

BPC-157 + TB-500: The Healing Stack

One of the most common peptide protocols combines BPC-157 and TB-500, taking advantage of their complementary mechanisms. BPC-157 excels at vascular repair and growth factor stimulation, while TB-500 specializes in inflammation resolution and cell mobilization. Together, they address multiple aspects of the healing cascade simultaneously.[6]

GHK-Cu: The Regenerative Tripeptide

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide first identified in human plasma. What makes it especially interesting from an aging perspective: GHK-Cu levels drop dramatically over a lifetime, from roughly 200 ng/mL at age 20 to about 80 ng/mL by age 60. That decline maps closely to the loss of regenerative capacity we associate with getting older.[5]

Key Properties

  • Collagen synthesis: Stimulates production of collagen types I and III, supporting structural tissue integrity
  • Gene expression modulation: Research shows GHK-Cu modulates expression of over 4,000 human genes, upregulating repair genes and downregulating destructive/inflammatory genes
  • Antioxidant: Protects tissues from oxidative damage, a key driver of aging and degenerative disease
  • Glycosaminoglycan production: Promotes production of proteoglycans essential for cartilage and connective tissue health
  • Wound healing: Extensively studied for skin wound healing, with applications extending to deeper tissue repair
  • Anti-aging: Broad regenerative effects position GHK-Cu as one of the most researched anti-aging peptides

GHK-Cu is used both topically (skin health) and systemically (subcutaneous injection for broader regenerative effects). It is a key peptide in our arthritis management protocols and connects closely with collagen peptide therapy.

How Healing Peptides Work

What makes healing peptides different from most pharmaceuticals is that they work through your body's own signaling infrastructure. They don't introduce foreign chemistry. They turn up the volume on repair processes that are already running:

The Healing Cascade

  • Inflammation phase: TB-500 and BPC-157 modulate the inflammatory response, ensuring it is effective without becoming chronic or destructive
  • Proliferation phase: BPC-157 stimulates angiogenesis and fibroblast proliferation. GHK-Cu promotes collagen synthesis. TB-500 mobilizes repair cells.
  • Remodeling phase: GHK-Cu supports extracellular matrix organization. BPC-157 promotes organized collagen alignment. TB-500 helps prevent excessive scarring.

The combination of these peptides addresses all three phases of tissue repair, which is why multi-peptide protocols often produce better outcomes than single-peptide approaches.

Conditions That May Benefit

In our clinical experience, and based on the published research, peptide therapy has shown promise for patients dealing with:

  • Tendon injuries: Tendinopathy, partial tears, post-surgical tendon repair
  • Joint health: Osteoarthritis, inflammatory arthritis, cartilage degeneration
  • Muscle injuries: Strains, tears, post-surgical muscle repair
  • Gut health: Inflammatory bowel conditions, leaky gut, NSAID-induced gastrointestinal damage
  • Post-surgical recovery: Accelerating healing after orthopedic or soft tissue surgery
  • Chronic inflammation: Persistent low-grade inflammation that impedes healing and recovery
  • Sports injuries: Full recovery support for athletic injuries
  • Age-related degeneration: Supporting tissue maintenance and repair capacity that declines with aging

Clinical Evidence Overview

Let's be straightforward about where the evidence stands. It ranges from a deep body of preclinical data to a smaller but growing set of human clinical evidence:

BPC-157

BPC-157 has the largest body of preclinical evidence, with hundreds of published studies across tissue types. Key findings include accelerated healing of tendons, ligaments, muscle, bone, and gastrointestinal tissue in animal models. Human clinical trials are limited but ongoing.[7]

TB-500 / Thymosin Beta-4

TB-500 research includes both animal studies and human clinical data, particularly in wound healing and cardiac applications. Thymosin Beta-4 has been evaluated in clinical trials for corneal healing, cardiac repair, and wound management.[4]

GHK-Cu

GHK-Cu has extensive research supporting its regenerative properties, with gene expression studies revealing modulation of over 4,000 genes. Clinical use in dermatology has established a strong safety record, and broader regenerative applications are being explored.[5]

We want to be transparent: the mechanistic rationale and preclinical evidence for healing peptides is strong, but large-scale human clinical trials for many applications are still in progress. That's exactly why physician supervision matters here. An experienced clinician can evaluate whether what we know today is enough to support peptide therapy for your specific condition, rather than applying a one-size-fits-all approach.

Our Treatment Approach

At Strong Health, every peptide therapy protocol follows a structured clinical framework:

  • Thorough evaluation: Medical history, physical examination, relevant imaging, and baseline lab work
  • Goal alignment: Clear discussion of treatment goals, expected timelines, and realistic outcomes
  • Individualized protocol: Physician designs a peptide protocol tailored to the patient's specific condition, health status, and goals
  • Quality assurance: All peptides are sourced from licensed compounding pharmacies with verified purity and potency
  • Patient education: Thorough training on self-administration technique, dosing schedule, and what to monitor
  • Ongoing monitoring: Regular follow-up appointments to assess progress, adjust protocols, and monitor for any adverse effects
  • Integrated care: Peptide therapy is coordinated with other treatments (physical therapy, nutrition, exercise) for optimal outcomes

Safety and Physician Supervision

Safety in peptide therapy comes down to three things, and cutting corners on any of them is a problem: peptide quality, appropriate dosing, and physician oversight.

Why Physician Supervision Matters

  • Proper diagnosis: Ensuring the underlying condition is correctly identified before treatment selection
  • Contraindication screening: Identifying conditions that may make peptide therapy inappropriate (active cancer, certain autoimmune conditions, pregnancy)
  • Drug interaction review: Evaluating potential interactions with current medications
  • Dosing optimization: Starting at appropriate doses and adjusting based on individual response
  • Quality assurance: Prescribing from licensed pharmacies rather than unregulated sources
  • Monitoring: Regular assessment of both therapeutic response and potential adverse effects
Strong Health does not recommend self-sourcing or self-administering research peptides without physician oversight. The peptide market includes products of variable quality, and without proper medical evaluation, patients risk inappropriate treatment, incorrect dosing, or missing contraindications. Every protocol we offer is designed, prescribed, and monitored by board-certified physicians.

For patients interested in specific applications, explore our detailed guides: tendon repair, libido, sleep, belly fat, muscle growth, arthritis, and collagen peptides.

Frequently Asked Questions

Related Articles

Find a Strong Health clinic near you

View all Florida locations →

Physician-supervised TRT and medical weight loss across 9 South Florida cities. Pick the location nearest you.

Miami-Dade County

Strong Health Miami
Brickell, Miami, FL
Strong Health Coral Gables
Miracle Mile, Coral Gables, FL
Strong Health Hialeah
Palm Avenue, Hialeah, FL
Strong Health Homestead
Krome Avenue, Homestead, FL

Broward County

Strong Health Fort Lauderdale
Las Olas, Fort Lauderdale, FL
Strong Health Hollywood
Young Circle, Hollywood, FL
Strong Health Pembroke Pines
Pines Boulevard, Pembroke Pines, FL

Palm Beach County

Strong Health Boca Raton
Mizner Park, Boca Raton, FL
Strong Health Delray Beach
Atlantic Avenue, Delray Beach, FL

Interested in Peptide Therapy?

Our physician team evaluates your health goals and determines if peptide therapy is right for you. Every protocol is individualized and physician-supervised.

References & Citations

  1. Seiwerth S, et al. BPC 157 and standard angiogenic growth factors: Gastrointestinal tract healing, lessons from tendon, ligament, muscle and bone healing. Curr Pharm Des. 2018;24(18):1972-1989.
  2. Sikiric P, et al. Brain-gut axis and pentadecapeptide BPC 157: Theoretical and practical implications. Curr Neuropharmacol. 2016;14(8):857-865.
  3. Malinda KM, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368.
  4. Sosne G, et al. Thymosin beta 4 promotes dermal healing. Ann N Y Acad Sci. 2007;1112:413-421.
  5. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987.
  6. Huff T, et al. Beta-thymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol. 2001;33(3):205-220.
  7. Sikiric P, et al. Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease. World J Gastroenterol. 2021;27(15):1584-1602.
  8. Junnila RK, et al. The GH/IGF-1 axis in ageing and longevity. Nat Rev Endocrinol. 2013;9(6):366-376.